TMEM16F Activators
TMEM16F Activators encompass a range of chemical compounds that facilitate the activation of TMEM16F by modulating cellular calcium levels and related signaling cascades. Ionomycin and A23187, both calcium ionophores, directly increase the intracellular calcium concentration, a crucial factor for the activation of TMEM16F's scramblase activity, vital for the exposure of phosphatidylserine on the cell surface. Arachidonic Acid and Prostaglandin E2, through their metabolites and signaling pathways, also enhance TMEM16F activity by affecting intracellular calcium dynamics and downstream signaling that could phosphorylate regulatory proteins associated with TMEM16F. Additionally, Dibucaine alters the lipid membrane properties, which may affect TMEM16F activity, suggesting a potential indirect activation mechanism via changes in the membrane environment where TMEM16F operates.
Compounds like Milrinone and Forskolin raise cAMP levels, which can lead to the activation of PKA, a kinase that could phosphorylate and thus regulate TMEM16F function. BAPTA-AM and Ruthenium Red, by modulating calcium levels, exert an influence on TMEM16F's activity. Thapsigargin, by inhibiting SERCA pumps, indirectly increases cytosolic calcium concentration, enhancing TMEM16F scramblase activity. TMEM16F Activators encompass a range of chemical compounds that facilitate the activation of TMEM16F by modulating cellular calcium levels and related signaling cascades. Ionomycin and A23187, both calcium ionophores, directly increase the intracellular calcium concentration, a crucial factor for the activation of TMEM16F's scramblase activity, vital for the exposure of phosphatidylserine on the cell surface. Arachidonic Acid and Prostaglandin E2, through their metabolites and signaling pathways, also enhance TMEM16F activity by affecting intracellular calcium dynamics and downstream signaling that could phosphorylate regulatory proteins associated with TMEM16F. Additionally, Dibucaine alters the lipid membrane properties, which may affect TMEM16F activity, suggesting a potential indirect activation mechanism via changes in the membrane environment where TMEM16F operates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium levels, which could indirectly enhance the phospholipid scramblase activity of TMEM16F, leading to exposure of phosphatidylserine on the cell surface. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
A fatty acid that can be metabolized into eicosanoids. These metabolites can modulate calcium-dependent activities, potentially increasing the scramblase activity of TMEM16F. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
A phosphodiesterase inhibitor that raises cAMP levels, which can lead to activation of PKA. PKA can phosphorylate regulatory proteins that modulate TMEM16F activity, enhancing its function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An adenylyl cyclase activator that increases intracellular cAMP, potentially leading to activation of pathways that enhance the activity of TMEM16F through phosphorylation events. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
A lipid compound that can activate signaling pathways involving cAMP, which may enhance TMEM16F scramblase activity through downstream phosphorylation processes. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A cell-permeable calcium chelator that, upon hydrolysis inside the cell, can buffer intracellular calcium levels, indirectly affecting the calcium-dependent activities of TMEM16F. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore similar to Ionomycin, which increases intracellular calcium levels and could thereby enhance the calcium-dependent activity of TMEM16F. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor that leads to increase in cytosolic calcium levels, potentially enhancing the calcium-activated scramblase activity of TMEM16F. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
An inhibitor of certain calcium channels that could modulate intracellular calcium levels, influencing the activation of TMEM16F. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $109.00 $160.00 $458.00 | 6 | |
A calcium channel blocker that can increase intracellular calcium by preventing its efflux, which could indirectly activate TMEM16F's scramblase activity. | ||||||